This report summarises a December 2018 meeting organised by the Hepatitis C Coalition to discuss hepatitis C and BBVs in prison. The report covers discussion points including the need for better implementation of opt-out testing, reducing points of attrition along the care pathway, tackling stigma and developing stronger links with community services.
Related resources
-
Hepatitis C Coalition Roundtable on HCV and Blood Borne Viruses in Prison
England 06 Feb 2019 Reports & Research, Strategy & Planning PDF -
Scotland: Report of the National Short Life Working Group (SLWG) on Hepatitis C Virus Case Finding and Access to Care
Following a request by the Scottish Government, a short life working group (SLWG) was convened and commissioned to develop recommendations on improvements in case-finding and treatment for hepatitis C in Scotland. The remit of the group was to review evidence and agree recommendations on four key topic areas: awareness-raising, case-finding, novel approaches to testing, and access to care. This report describes the methodology, key findings, and recommendations of the SLWG.Scotland Reports & Research PDF -
World Hepatitis Day 2018: Global Summary Report
This report, produced by the World Hepatitis Alliance, provides a comprehensive summary of international activity for World Hepatitis Day 2018. 144 countries, 93 governments and 53 WHO Country Offices took part across the six regions. Over 1,600 events were organised, 318,914 people attended events in their local community or country, and millions were reached online.UK, Rest of World 18 Dec 2018 Reports & Research PDF -
Antiviral resistance testing in the management of hepatitis C virus infection
This report from the Public Health England Hepatitis C Virus Resistance Group to support clinicians treating people with HCV, where the issue of resistance may be a factor in clinical decision-making.England 17 Dec 2018 Reports & Research PDF -
Hepatitis C treatment monitoring in England
This Public Health England resource contains data and findings from the hepatitis C patient registry and treatment outcome system. Data from the registry shows that DAA treatments have successfully cured 95% of patients who received them. The vast majority of treatment continues to take place within secondary care, with just 13% of treatments undertaken in drug services, prisons or other outreach settings.England 21 Nov 2018 Reports & Research PDF